Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer

Classifying indolent prostate cancer represents a significant clinical challenge. We investigated whether integrating data from different omic platforms could identify a biomarker panel with improved performance compared to individual platforms alone. DNA methylation, transcripts, protein and glycos...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Keefe, Murphy, Brendan T., Boyce, Susie, Flynn, Louise, Gilgunn, Sarah, O'Rourke, Colm J., Rooney, Cathy, Stöckmann, Henning, Walsh, Anna L., Finn, Stephen, O'Kennedy, Richard J., O'Leary, John, Pennington, Stephen R., Perry, Antoinette S., Rudd, Pauline M., Saldova, Radka, Sheils, Orla, Shields, Denis C., Watson, R. William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120220/
https://www.ncbi.nlm.nih.gov/pubmed/29927052
http://dx.doi.org/10.1002/1878-0261.12348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120220/
https://www.ncbi.nlm.nih.gov/pubmed/29927052
http://dx.doi.org/10.1002/1878-0261.12348

Ejemplares similares